# Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve

Study · id `cardio:ct-nct02541877` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02541877](<https://clinicaltrials.gov/study/NCT02541877>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02541877

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 159 participants.

## Technical summary

Registry record NCT02541877. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2018-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 159 participants (planned count; ClinicalTrials.gov record NCT02541877, source copy `cardio:ctgov-nct02541877-2015-09-04`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02541877, source copy `cardio:ctgov-nct02541877-2015-09-04`, retrieved 2026-10-26)
- Primary completion: 2018-09 (anticipated) (ClinicalTrials.gov record NCT02541877, source copy `cardio:ctgov-nct02541877-2015-09-04`, retrieved 2026-10-26)
- Completion: 2023-09 (anticipated) (ClinicalTrials.gov record NCT02541877, source copy `cardio:ctgov-nct02541877-2015-09-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02541877, source copy `cardio:ctgov-nct02541877-2015-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02541877-2015-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve
- Acronym: START
- Condition: Aortic Valve Stenosis
- Intervention (Device): Down sizing valve in type-0 BAS
- Intervention (Device): Standard sizing valve in type-0 BAS
- Intervention (Device): Standard sizing valve in TAS
- Lead sponsor: Jian'an Wang,MD,PhD
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 7afbf5f1fb013630c92bb2500691794e72f816c34b6d908b51f01b3f494788d9
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
